Literature DB >> 3494088

Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis.

J Black, T L Hunt, P J Godley, E Matthew.   

Abstract

We conducted a retrospective review of 21 adult patients with osteomyelitis and septic arthritis who were treated with high doses of oral antimicrobial agents, usually after an initial course of intravenous therapy. The mean duration of parenteral and oral therapy was 3.6 days and 43.0 days, respectively. Absorption of oral antibiotics was assessed by determining the trough serum bactericidal titers for the infecting organism; whenever feasible, the dosages were adjusted to achieve trough titers greater than or equal to 1:8. The follow-up period ranged from six to 66 months (mean, 42.4 months). Eighteen of 21 patients had no clinical signs of recurrence after initial therapy. One patient with an infected joint prosthesis developed recurrent infection, and two patients had recurrences accompanied by sequestra. The mean duration of hospitalization was 13.4 days, and the mean duration of outpatient treatment was 31.9 days.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494088     DOI: 10.1093/infdis/155.5.968

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Intravenous-to-oral conversion therapy for antimicrobials.

Authors:  J M Conly; S D Shafran
Journal:  Can J Infect Dis       Date:  1994-01

Review 2.  A practical guide to the diagnosis and management of bone and joint infections.

Authors:  J T Mader; D Mohan; J Calhoun
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 3.  Pharmacokinetic optimisation of the treatment of septic arthritis.

Authors:  K A Hamed; J Y Tam; C G Prober
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 4.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Clinical sequelae and sacroiliac joint changes by computed tomography after recovery from septic sacroiliitis.

Authors:  M Haanpää; P Hannonen; P Kaira; J Laurikainen; T T Möttönen; M Oka
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

6.  Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.

Authors:  R Dworkin; G Modin; S Kunz; R Rich; O Zak; M Sande
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  The significance of osteitis in rhinosinusitis.

Authors:  Neeraj Sethi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-27       Impact factor: 2.503

8.  In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model.

Authors:  Olivier Grossi; Jocelyne Caillon; Cedric Arvieux; Cedric Jacqueline; Denis Bugnon; Gilles Potel; Antoine Hamel
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

Review 9.  Optimum treatment of staphylococcal infections.

Authors:  J Turnidge; M L Grayson
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 10.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.